China National Medicines Corporation Ltd. Selling, General, and Administrative Expenses (SG&A) for the year ending December 31, 2024: USD 61.39 M

China National Medicines Corporation Ltd. Selling, General, and Administrative Expenses (SG&A) is USD 61.39 M for the year ending December 31, 2024, a -26.63% change year over year. Selling, general, and administrative (SG&A) expenses are the expenses related to the sales and marketing efforts, as well as general and administrative functions of a company.
  • China National Medicines Corporation Ltd. Selling, General, and Administrative Expenses (SG&A) for the year ending December 31, 2023 was USD 83.66 M, a -42.84% change year over year.
  • China National Medicines Corporation Ltd. Selling, General, and Administrative Expenses (SG&A) for the year ending December 31, 2022 was USD 146.37 M, a -6.72% change year over year.
  • China National Medicines Corporation Ltd. Selling, General, and Administrative Expenses (SG&A) for the year ending December 31, 2021 was USD 156.92 M, a -4.96% change year over year.
  • China National Medicines Corporation Ltd. Selling, General, and Administrative Expenses (SG&A) for the year ending December 31, 2020 was USD 165.12 M, a 3.95% change year over year.
Key Data
Date Selling, General, and Administrative Expenses (SG&A) Research and Development (R&D) Expenses Revenue Revenue